{"date":"2026-03-18","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6620-2026-03-18-1912-1dyccx7","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"19:12:18","subject":"本公司受邀參加第一金證券舉辦之實體暨線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-18 19:12，「本公司受邀參加第一金證券舉辦之實體暨線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-18-1843-dqh4gv","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"18:43:18","subject":"公告本公司114年度現金增資收足股款暨增資基準日","clause":"第9款","fact_date":"2026-03-18","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-18 18:43，「公告本公司114年度現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-03-18-1831-10jca0t","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"18:31:31","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-03-18 18:31，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-03-18-1827-10jca0t","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-03-18","time":"18:27:38","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-03-18 18:27，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-03-18-1818-1tnj5a6","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"18:18:05","subject":"本公司會計主管、財務主管、代理發言人異動","clause":"第11款","fact_date":"2026-03-18","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-03-18 18:18，「本公司會計主管、財務主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-18-1807-11tcr0b","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"18:07:20","subject":"更正本公司買回庫藏股期間屆滿執行情形 - 更正將已買回股份總金額加入手續費，買回均價同步更新。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-18 18:07，「更正本公司買回庫藏股期間屆滿執行情形 - 更正將已買回股份總金額加入手續費，買回均價同步更新。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-03-18-1716-5rax5d","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"17:16:00","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-03-18 17:16，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-18-1659-ps7z81","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"16:59:06","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-18 16:59，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-18-1657-7tusd8","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"16:57:51","subject":"公告本公司董事及獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-18 16:57，「公告本公司董事及獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-18-1622-1ba6fw5","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-18","time":"16:22:05","subject":"(補充114/12/10公告)公告本公司董事會決議通過擬與Advanced Cyclotron Systems Inc.簽署加速器技術授權移轉案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-18 16:22，「(補充114/12/10公告)公告本公司董事會決議通過擬與Advanced Cyclotron Systems Inc.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-18-1612-18jhpk0","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"16:12:29","subject":"更新115.3.12公告本公司董事會決議通過一一四年下半年度盈餘分派股利之第(8)事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-18 16:12，「更新115.3.12公告本公司董事會決議通過一一四年下半年度盈餘分派股利之第(8)事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-18-1603-q8ozau","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"16:03:43","subject":"公告本公司董事會決議辦理初次上櫃掛牌前現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-18 16:03，「公告本公司董事會決議辦理初次上櫃掛牌前現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-18-1603-yclg0e","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"16:03:12","subject":"公告本公司因會計師事務所內部輪調更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-18 16:03，「公告本公司因會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-18-1549-1hrxqxy","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-18","time":"15:49:55","subject":"本公司於美國對Azurity Pharmaceuticals, Inc.提出侵害營業秘密、違反保密協議及不正當競爭之訴訟","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-18 15:49，「本公司於美國對Azurity Pharmaceuticals, Inc.提出侵害營業秘密、違反保密協議及不正當競爭之訴訟」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-18-1423-7f3nd4","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"14:23:01","subject":"本公司受邀參加富邦證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-18 14:23，「本公司受邀參加富邦證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-18-1412-hdxnfu","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-18","time":"14:12:51","subject":"補正本公司114年第四季合併及個體財務報表附註","clause":"第51款","fact_date":"2026-03-18","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-18 14:12，「補正本公司114年第四季合併及個體財務報表附註」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-03-18-1354-oz6nrh","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-03-18","time":"13:54:35","subject":"公告本公司董事會決議召開本公司115年股東常會","clause":"第17款","fact_date":"2026-03-18","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-03-18 13:54，「公告本公司董事會決議召開本公司115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-18-0611-a4euwk","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-18","time":"06:11:44","subject":"本公司新藥Pidnarulex (CX-5461)應用於全新突破性光動力療法，可顯著提升抗腫瘤活性及存活率的試驗成果摘要，獲選將於美國癌症研究協會AACR2026年會以海報形式發表。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-18 06:11，「本公司新藥Pidnarulex (CX-5461)應用於全新突破性光動力療法，可顯著提升抗腫瘤活性及存活率的試驗成果摘要」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}